🔎 Trials Near Me

Akèy › Skleroderm Difize › New York › New York City

Etid klinik pou Skleroderm Difize nan New York City, NY

8 etid pou Skleroderm Difize ap chèche patisipan nan sit nan ak bò kote New York City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Ap rekriteFaz 2
  • Hospital for Special Surgery, New York
Laj 18 a 70 · Tout sèks · Mizajou Sep 28, 2026 · NCT06470048

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Ap rekriteFaz 1
  • Icahn School of Medicine at Mount Sinai, New York
Laj 18 a 74 · Tout sèks · Mizajou Sep 10, 2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Ap rekriteFaz 2/3
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05878717

Platform Clinical Study for Conquering Scleroderma

Ap rekriteFaz 2
  • Hospital for Special Surgery, New York
  • Columbia University Medical Center, New York
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Ap rekriteFaz 2/3
  • Columbia University Irving Medical Center, New York
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Ap rekriteFaz 1/2
  • Nkarta Investigational Site, New York
Laj 18 a 75 · Tout sèks · Mizajou Aug 7, 2026 · NCT06733935

Scleroderma Registry & Repository at the Hospital for Special Surgery

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Hospital for Special Surgery, New York
Laj 18 ak plis · Tout sèks · Mizajou Nov 26, 2025 · NCT01656447

Etid Skleroderm Difize nan lòt vil

Lòt etid nan New York City

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.